<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2134904/" ref="ordinalpos=1907&amp;ncbi_uid=1188398&amp;link_uid=PMC2134904" image-link="/pmc/articles/PMC2134904/figure/F7/" class="imagepopup">Figure 7.  From: Statins Stimulate In Vitro Membrane FasL Expression and Lymphocyte Apoptosis through RhoA/ROCK <span class="highlight" style="background-color:">Pathway</span> in Murine Melanoma Cells. </a></div><br /><div class="p4l_captionBody">Schematic representation of the effects of RhoA/ROCK signaling pathway inhibition on membrane FasL expression and lymphocytes apoptosis. In vitro treatments of B16F10 melanoma cells with inhibitors of the RhoA/ROCK pathway increase the membrane FasL expression on these treated tumor cells. This (over)expression promoted the apoptosis of Fas-sensitive lymphocytes.</div></div>